[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global T-Cell Immunotherapy Sales Market Report 2017

January 2017 | 120 pages | ID: G929BE4EA0DEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of T-Cell Immunotherapy

Revenue, means the sales value of T-Cell Immunotherapy

This report studies sales (consumption) of T-Cell Immunotherapy in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Adaptimmune
  • Altor Bioscience Corporation
  • Cellectis
  • Cell Therapy Catapult
  • Juno Therapeutics
  • Kite Pharma
  • Novartis
  • Takara Bio
  • Unum Therapeutics
  • Abingworth
  • ARCH Venture Partners
  • Acorn Campus Ventures
  • Adaptimmune
  • AFA F?rs?kring
  • AGF Private Equity
  • AgonOx
  • Agreen Biotech
  • Aju IB Investment
  • Alaska Permanent Fund
  • Alexandria Ventures
  • Allos Therapeutics
  • Amgen
  • Applied Immune Technologies
  • Aquilo Capital Management
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of T-Cell Immunotherapy in these regions, from 2011 to 2021 (forecast), like
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • CAR-T
  • TCR
  • TIL Therapies
Split by applications, this report focuses on sales, market share and growth rate of T-Cell Immunotherapy in each application, can be divided into
  • Hematological Malignancies
  • Solid Tumors
  • Others
Global T-Cell Immunotherapy Sales Market Report 2017

1 T-CELL IMMUNOTHERAPY OVERVIEW

1.1 Product Overview and Scope of T-Cell Immunotherapy
1.2 Classification of T-Cell Immunotherapy
  1.2.1 CAR-T
  1.2.2 TCR
  1.2.3 TIL Therapies
1.3 Application of T-Cell Immunotherapy
  1.3.1 Hematological Malignancies
  1.3.2 Solid Tumors
  1.3.3 Others
1.4 T-Cell Immunotherapy Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of T-Cell Immunotherapy (2012-2022)
  1.5.1 Global T-Cell Immunotherapy Sales and Growth Rate (2012-2022)
  1.5.2 Global T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

2 GLOBAL T-CELL IMMUNOTHERAPY COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global T-Cell Immunotherapy Market Competition by Manufacturers
  2.1.1 Global T-Cell Immunotherapy Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global T-Cell Immunotherapy Revenue and Share by Manufacturers (2012-2017)
2.2 Global T-Cell Immunotherapy (Volume and Value) by Type
  2.2.1 Global T-Cell Immunotherapy Sales and Market Share by Type (2012-2017)
  2.2.2 Global T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)
2.3 Global T-Cell Immunotherapy (Volume and Value) by Regions
  2.3.1 Global T-Cell Immunotherapy Sales and Market Share by Regions (2012-2017)
  2.3.2 Global T-Cell Immunotherapy Revenue and Market Share by Regions (2012-2017)
2.4 Global T-Cell Immunotherapy (Volume) by Application

3 UNITED STATES T-CELL IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

3.1 United States T-Cell Immunotherapy Sales and Value (2012-2017)
  3.1.1 United States T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
  3.1.2 United States T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
  3.1.3 United States T-Cell Immunotherapy Sales Price Trend (2012-2017)
3.2 United States T-Cell Immunotherapy Sales and Market Share by Manufacturers
3.3 United States T-Cell Immunotherapy Sales and Market Share by Type
3.4 United States T-Cell Immunotherapy Sales and Market Share by Application

4 CHINA T-CELL IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

4.1 China T-Cell Immunotherapy Sales and Value (2012-2017)
  4.1.1 China T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
  4.1.2 China T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
  4.1.3 China T-Cell Immunotherapy Sales Price Trend (2012-2017)
4.2 China T-Cell Immunotherapy Sales and Market Share by Manufacturers
4.3 China T-Cell Immunotherapy Sales and Market Share by Type
4.4 China T-Cell Immunotherapy Sales and Market Share by Application

5 EUROPE T-CELL IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

5.1 Europe T-Cell Immunotherapy Sales and Value (2012-2017)
  5.1.1 Europe T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
  5.1.2 Europe T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
  5.1.3 Europe T-Cell Immunotherapy Sales Price Trend (2012-2017)
5.2 Europe T-Cell Immunotherapy Sales and Market Share by Manufacturers
5.3 Europe T-Cell Immunotherapy Sales and Market Share by Type
5.4 Europe T-Cell Immunotherapy Sales and Market Share by Application

6 JAPAN T-CELL IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

6.1 Japan T-Cell Immunotherapy Sales and Value (2012-2017)
  6.1.1 Japan T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
  6.1.2 Japan T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
  6.1.3 Japan T-Cell Immunotherapy Sales Price Trend (2012-2017)
6.2 Japan T-Cell Immunotherapy Sales and Market Share by Manufacturers
6.3 Japan T-Cell Immunotherapy Sales and Market Share by Type
6.4 Japan T-Cell Immunotherapy Sales and Market Share by Application

7 SOUTHEAST ASIA T-CELL IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia T-Cell Immunotherapy Sales and Value (2012-2017)
  7.1.1 Southeast Asia T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia T-Cell Immunotherapy Sales Price Trend (2012-2017)
7.2 Southeast Asia T-Cell Immunotherapy Sales and Market Share by Manufacturers
7.3 Southeast Asia T-Cell Immunotherapy Sales and Market Share by Type
7.4 Southeast Asia T-Cell Immunotherapy Sales and Market Share by Application

8 INDIA T-CELL IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

8.1 India T-Cell Immunotherapy Sales and Value (2012-2017)
  8.1.1 India T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
  8.1.2 India T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
  8.1.3 India T-Cell Immunotherapy Sales Price Trend (2012-2017)
8.2 India T-Cell Immunotherapy Sales and Market Share by Manufacturers
8.3 India T-Cell Immunotherapy Sales and Market Share by Type
8.4 India T-Cell Immunotherapy Sales and Market Share by Application

9 GLOBAL T-CELL IMMUNOTHERAPY MANUFACTURERS ANALYSIS

9.1 Adaptimmune
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 T-Cell Immunotherapy Product Type, Application and Specification
    9.1.2.1 CAR-T
    9.1.2.2 TCR
  9.1.3 Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Altor Bioscience Corporation
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 T-Cell Immunotherapy Product Type, Application and Specification
    9.2.2.1 CAR-T
    9.2.2.2 TCR
  9.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Cellectis
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 T-Cell Immunotherapy Product Type, Application and Specification
    9.3.2.1 CAR-T
    9.3.2.2 TCR
  9.3.3 Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Cell Therapy Catapult
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 T-Cell Immunotherapy Product Type, Application and Specification
    9.4.2.1 CAR-T
    9.4.2.2 TCR
  9.4.3 Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Juno Therapeutics
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 T-Cell Immunotherapy Product Type, Application and Specification
    9.5.2.1 CAR-T
    9.5.2.2 TCR
  9.5.3 Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Kite Pharma
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 T-Cell Immunotherapy Product Type, Application and Specification
    9.6.2.1 CAR-T
    9.6.2.2 TCR
  9.6.3 Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Novartis
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 T-Cell Immunotherapy Product Type, Application and Specification
    9.7.2.1 CAR-T
    9.7.2.2 TCR
  9.7.3 Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Takara Bio
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 T-Cell Immunotherapy Product Type, Application and Specification
    9.8.2.1 CAR-T
    9.8.2.2 TCR
  9.8.3 Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Unum Therapeutics
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 T-Cell Immunotherapy Product Type, Application and Specification
    9.9.2.1 CAR-T
    9.9.2.2 TCR
  9.9.3 Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Abingworth
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 T-Cell Immunotherapy Product Type, Application and Specification
    9.10.2.1 CAR-T
    9.10.2.2 TCR
  9.10.3 Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 ARCH Venture Partners
9.12 Acorn Campus Ventures
9.13 Adaptimmune
9.14 AFA F?rs?kring
9.15 AGF Private Equity
9.16 AgonOx
9.17 Agreen Biotech
9.18 Aju IB Investment
9.19 Alaska Permanent Fund
9.20 Alexandria Ventures
9.21 Allos Therapeutics
9.22 Amgen
9.23 Applied Immune Technologies
9.24 Aquilo Capital Management

10 T-CELL IMMUNOTHERAPY MAUFACTURING COST ANALYSIS

10.1 T-Cell Immunotherapy Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of T-Cell Immunotherapy
10.3 Manufacturing Process Analysis of T-Cell Immunotherapy

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 T-Cell Immunotherapy Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL T-CELL IMMUNOTHERAPY MARKET FORECAST (2017-2022)

14.1 Global T-Cell Immunotherapy Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global T-Cell Immunotherapy Price and Trend Forecast (2017-2022)
14.2 Global T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global T-Cell Immunotherapy Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global T-Cell Immunotherapy Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of T-Cell Immunotherapy
Table Classification of T-Cell Immunotherapy
Figure Global Sales Market Share of T-Cell Immunotherapy by Type in 2015
Figure CAR-T Picture
Figure TCR Picture
Figure TIL Therapies Picture
Table Applications of T-Cell Immunotherapy
Figure Global Sales Market Share of T-Cell Immunotherapy by Application in 2015
Figure Hematological Malignancies Examples
Figure Solid Tumors Examples
Figure Others Examples
Figure United States T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure China T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure Europe T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure Japan T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure Southeast Asia T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure India T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure Global T-Cell Immunotherapy Sales and Growth Rate (2012-2022)
Figure Global T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Table Global T-Cell Immunotherapy Sales of Key Manufacturers (2012-2017)
Table Global T-Cell Immunotherapy Sales Share by Manufacturers (2012-2017)
Figure 2015 T-Cell Immunotherapy Sales Share by Manufacturers
Figure 2016 T-Cell Immunotherapy Sales Share by Manufacturers
Table Global T-Cell Immunotherapy Revenue by Manufacturers (2012-2017)
Table Global T-Cell Immunotherapy Revenue Share by Manufacturers (2012-2017)
Table 2015 Global T-Cell Immunotherapy Revenue Share by Manufacturers
Table 2016 Global T-Cell Immunotherapy Revenue Share by Manufacturers
Table Global T-Cell Immunotherapy Sales and Market Share by Type (2012-2017)
Table Global T-Cell Immunotherapy Sales Share by Type (2012-2017)
Figure Sales Market Share of T-Cell Immunotherapy by Type (2012-2017)
Figure Global T-Cell Immunotherapy Sales Growth Rate by Type (2012-2017)
Table Global T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)
Table Global T-Cell Immunotherapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of T-Cell Immunotherapy by Type (2012-2017)
Figure Global T-Cell Immunotherapy Revenue Growth Rate by Type (2012-2017)
Table Global T-Cell Immunotherapy Sales and Market Share by Regions (2012-2017)
Table Global T-Cell Immunotherapy Sales Share by Regions (2012-2017)
Figure Sales Market Share of T-Cell Immunotherapy by Regions (2012-2017)
Figure Global T-Cell Immunotherapy Sales Growth Rate by Regions (2012-2017)
Table Global T-Cell Immunotherapy Revenue and Market Share by Regions (2012-2017)
Table Global T-Cell Immunotherapy Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of T-Cell Immunotherapy by Regions (2012-2017)
Figure Global T-Cell Immunotherapy Revenue Growth Rate by Regions (2012-2017)
Table Global T-Cell Immunotherapy Sales and Market Share by Application (2012-2017)
Table Global T-Cell Immunotherapy Sales Share by Application (2012-2017)
Figure Sales Market Share of T-Cell Immunotherapy by Application (2012-2017)
Figure Global T-Cell Immunotherapy Sales Growth Rate by Application (2012-2017)
Figure United States T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure United States T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure United States T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table United States T-Cell Immunotherapy Sales by Manufacturers (2012-2017)
Table United States T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)
Table United States T-Cell Immunotherapy Sales by Type (2012-2017)
Table United States T-Cell Immunotherapy Market Share by Type (2012-2017)
Table United States T-Cell Immunotherapy Sales by Application (2012-2017)
Table United States T-Cell Immunotherapy Market Share by Application (2012-2017)
Figure China T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure China T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure China T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table China T-Cell Immunotherapy Sales by Manufacturers (2012-2017)
Table China T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)
Table China T-Cell Immunotherapy Sales by Type (2012-2017)
Table China T-Cell Immunotherapy Market Share by Type (2012-2017)
Table China T-Cell Immunotherapy Sales by Application (2012-2017)
Table China T-Cell Immunotherapy Market Share by Application (2012-2017)
Figure Europe T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure Europe T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Europe T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table Europe T-Cell Immunotherapy Sales by Manufacturers (2012-2017)
Table Europe T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)
Table Europe T-Cell Immunotherapy Sales by Type (2012-2017)
Table Europe T-Cell Immunotherapy Market Share by Type (2012-2017)
Table Europe T-Cell Immunotherapy Sales by Application (2012-2017)
Table Europe T-Cell Immunotherapy Market Share by Application (2012-2017)
Figure Japan T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure Japan T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Japan T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table Japan T-Cell Immunotherapy Sales by Manufacturers (2012-2017)
Table Japan T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)
Table Japan T-Cell Immunotherapy Sales by Type (2012-2017)
Table Japan T-Cell Immunotherapy Market Share by Type (2012-2017)
Table Japan T-Cell Immunotherapy Sales by Application (2012-2017)
Table Japan T-Cell Immunotherapy Market Share by Application (2012-2017)
Figure Southeast Asia T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure Southeast Asia T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Southeast Asia T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table Southeast Asia T-Cell Immunotherapy Sales by Manufacturers (2012-2017)
Table Southeast Asia T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)
Table Southeast Asia T-Cell Immunotherapy Sales by Type (2012-2017)
Table Southeast Asia T-Cell Immunotherapy Market Share by Type (2012-2017)
Table Southeast Asia T-Cell Immunotherapy Sales by Application (2012-2017)
Table Southeast Asia T-Cell Immunotherapy Market Share by Application (2012-2017)
Figure India T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure India T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure India T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table India T-Cell Immunotherapy Sales by Manufacturers (2012-2017)
Table India T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)
Table India T-Cell Immunotherapy Sales by Type (2012-2017)
Table India T-Cell Immunotherapy Market Share by Type (2012-2017)
Table India T-Cell Immunotherapy Sales by Application (2012-2017)
Table India T-Cell Immunotherapy Market Share by Application (2012-2017)
Table Adaptimmune Basic Information List
Table Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Adaptimmune T-Cell Immunotherapy Global Market Share (2012-2017)
Table Altor Bioscience Corporation Basic Information List
Table Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Altor Bioscience Corporation T-Cell Immunotherapy Global Market Share (2012-2017)
Table Cellectis Basic Information List
Table Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cellectis T-Cell Immunotherapy Global Market Share (2012-2017)
Table Cell Therapy Catapult Basic Information List
Table Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cell Therapy Catapult T-Cell Immunotherapy Global Market Share (2012-2017)
Table Juno Therapeutics Basic Information List
Table Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Juno Therapeutics T-Cell Immunotherapy Global Market Share (2012-2017)
Table Kite Pharma Basic Information List
Table Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kite Pharma T-Cell Immunotherapy Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis T-Cell Immunotherapy Global Market Share (2012-2017)
Table Takara Bio Basic Information List
Table Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Takara Bio T-Cell Immunotherapy Global Market Share (2012-2017)
Table Unum Therapeutics Basic Information List
Table Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Unum Therapeutics T-Cell Immunotherapy Global Market Share (2012-2017)
Table Abingworth Basic Information List
Table Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abingworth T-Cell Immunotherapy Global Market Share (2012-2017)
Table ARCH Venture Partners Basic Information List
Table Acorn Campus Ventures Basic Information List
Table Adaptimmune Basic Information List
Table AFA F?rs?kring Basic Information List
Table AGF Private Equity Basic Information List
Table AgonOx Basic Information List
Table Agreen Biotech Basic Information List
Table Aju IB Investment Basic Information List
Table Alaska Permanent Fund Basic Information List
Table Alexandria Ventures Basic Information List
Table Allos Therapeutics Basic Information List
Table Amgen Basic Information List
Table Applied Immune Technologies Basic Information List
Table Aquilo Capital Management Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of T-Cell Immunotherapy
Figure Manufacturing Process Analysis of T-Cell Immunotherapy
Figure T-Cell Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015
Table Major Buyers of T-Cell Immunotherapy
Table Distributors/Traders List
Figure Global T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Global T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
Table Global T-Cell Immunotherapy Sales Forecast by Regions (2017-2022)
Table Global T-Cell Immunotherapy Sales Forecast by Type (2017-2022)
Table Global T-Cell Immunotherapy Sales Forecast by Application (2017-2022)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories